Skip to main content
Retour
Watch Compare

SANUWAVE Health, Inc.

Qualité des données : 100%
SNWV
Nasdaq Manufacturing Measuring & Analyzing Instruments
16,84 €
▼ 1,32 € (-7,27%)
Cap. Boursière: 155,56 M
Prix
18,10 €
Cap. Boursière
155,56 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 35,65% annually over 5 years — strong growth
Net margin of 26,82% shows strong profitability
Generating 1,93 M in free cash flow
P/E of 13,17 — trading at a low valuation
Capital efficient — spends only 4,41% of revenue on capex
ROIC of 382,49% — excellent capital efficiency

Croissance

Revenue Growth (5Y)
35,65%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)34,98%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC382,49%
Net Margin26,82%
Op. Margin11,23%

Sécurité

Debt / Equity
N/A
Current Ratio1,16
Interest Coverage0,88

Valorisation

PE (TTM|2027)
13,17 | 18,76
Au-dessus de la moyenne du secteur (-1,47)
P/B RatioN/A
EV/EBITDA28,59
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 13,2 -1,5
P/B — 1,6
ROE % — -53,3
Net Margin % 26,8 -41,5
Rev Growth 5Y % 35,7 1,8
D/E — 0,3

Objectif de Cours des Analystes

2 analystes
Buy
Actuel
16,84 €
+158.3%
Objectif
43,50 €
40,00 €
43,50 €
47,00 €
Prévisions
P/E Prévisionnel 17,45
BPA Prévisionnel 0,97 €
Croissance BPA (est.) +141,3%
CA Est. 65,34 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 0,97 €
0,37 € – 1,56 €
 65,34 M 2
FY2026 0,40 €
-0,06 € – 0,86 €
 52,07 M 2

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 0,17 € 0,03 € -82,4%
Q32025 0,32 € 0,46 € +43,8%
Q22025 -0,09 € 0,01 € +111,1%
Q12025 N/A -0,66 € —

ETFs Holding This Stock

BRUSX BRUSX
0,97% weight
GSMRX GSMRX
0,05% weight
GISMX GISMX
0,05% weight
GMSMX GMSMX
0,05% weight
FLQS FLQS
0,02% weight
IRSSX IRSSX
0,01% weight
VVICX VVICX
0,01% weight
IRCIX IRCIX
0,01% weight
IIRSX IIRSX
0,01% weight
IRSIX IRSIX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 34,98% Revenue Growth (3Y) 46,95%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 35,65% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 44,05 M Net Income (TTM) 11,81 M
ROE N/A ROA 34,42%
Gross Margin 77,11% Operating Margin 11,23%
Net Margin 26,82% Free Cash Flow (TTM) 1,93 M
ROIC 382,49% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,16
Interest Coverage 0,88 Asset Turnover 1,28
Working Capital 3,06 M Tangible Book Value -13,39 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 13,17 Forward P/E N/A
P/B Ratio N/A P/S Ratio 3,53
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 28,59 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1,24%
Market Cap 155,56 M Enterprise Value 169,24 M
Per Share
EPS (Diluted TTM) 0,41 Revenue / Share 5,13
FCF / Share 0,23 OCF / Share 0,45
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 4,41% FCF Conversion 16,37%
SBC-Adj. FCF -1,58 M Growth Momentum -0,67

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 44,05 M 32,63 M 20,40 M 16,74 M 13,01 M
Net Income 11,81 M -31,37 M -25,81 M -10,29 M -27,26 M
EPS (Diluted) 0,41 -7,03 -0,03 -0,02 -0,05
Gross Profit 33,97 M 24,55 M 14,36 M 12,41 M 8,02 M
Operating Income 4,95 M 5,42 M -540 000,0 -8,95 M -14,14 M
EBITDA — — — — —
R&D Expenses 1,35 M 673 000,0 579 000,0 567 000,0 1,10 M
SG&A Expenses — — — — —
D&A 974 000,0 1,15 M 1,03 M 952 000,0 532 000,0
Interest Expense 5,64 M — — 12,77 M 6,88 M
Income Tax 86 000,0 27 000,0 4 000,0 2 000,0 28 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 37,34 M 30,12 M 22,42 M 19,87 M 18,62 M
Total Liabilities 35,72 M 42,84 M 65,59 M 60,88 M 57,58 M
Shareholders' Equity 1,62 M -12,72 M -43,18 M -41,01 M -38,96 M
Total Debt 21,89 M — — 1,48 M 26,26 M
Cash & Equivalents 11,96 M 10,24 M 1,80 M 1,15 M 619 000,0
Current Assets 24,63 M 18,40 M 9,78 M 6,62 M 4,40 M
Current Liabilities 17,85 M 42,35 M 64,76 M 60,19 M 56,26 M